Chronic Disease Management

Clinical Practice in Correctional Medicine

Volumn , Issue , 2006, Pages 66-88

  Puisis, Michael ^a   Appel, Harold ^a,b  

^a Department of Health and Mental Hygiene ^*

^b MANHATTAN PSYCHIATRIC CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846459768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03265-0.50012-9     Document Type: Chapter

References (77)

1. The Institute for Health and Aging, University of California, San Francisco, for the Robert Wood Johnson Foundation Chronic Care in America: A 21st Century Challenge. Princeton, New Jersey, November 1966,.
2. Bureau of Justice Statistics, Bulletin: Prisoners in 2003. Washington, DC, NCJ 203947, May 2004.
3. Centers for Disease Control and Prevention: The Burden of Chronic Disease and the Future of Public Health, a presentation, January 13, 2003.
4. The Health Status of Soon-To-Be-Released Inmates, A Report to Congress, Volume 1. National Commission on Correctional Health Care, March 2002.
5. Institute of Medicine Crossing the Quality Chasm: A New Health System for the Twenty-first Century 2003, National Academy Press, Washington, DC.
6. Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: Translating evidence into action. Health Aff 2001, 20(6):64-78.
7. Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: Quality of care in the 1990s. Ann Intern Med 2002, 136(8):565-574.
8. Improving Chronic Illness, A National Program of The Robert Wood Johnson Foundation, at. http://www.improvingchroniccare.org/index.html.
9. Bodenheimer T, Wagner EH, Grumbach K Improving primary care for patients with chronic illness, the chronic care model, part 2. JAMA 2002, 288(15):1909-1914.
10. Standards for Health Care in Prisons, National Commission on Correctional Health Care, 2003.
11. Standards for Health Care in Jails, National Commission on Correctional Health Care, 2003.
12. Steven Rosen v. City of Philadelphia, United States District Court for the Eastern District of Pennsylvania, Civil Action No. 2000-CV-764.
13. Inmate dies after pleas were ignored, prisoners say: Jennifer Fitzenberger. Milwaukee Journal Sentinel 1999, Monday, August 2.
14. Nurse fired after death of baby born in jail: Jill King Greenwood, Tampa Tribune, April 10, 2004.
15. Bodenheimer T, Lorig K, Holman H, et al. Patient self-management of chronic disease in primary care:. JAMA 2002, 288(19):2469-2475.
16. Von Korff M, Gruman J, Schaefer J, et al. Collaborative management of chronic illness. Ann Intern Med 1997, 127(12):1097-1102.
17. Curry SJ, McBride CM Relapse prevention for smoking cessation: Review and evaluation of concepts and interventions. Annual Review of Public Health 1994, 345-366. Annual Reviews, Palo Alto, CA. G.S. Omenn, J.E. Fielding, L.B. Lave (Eds.).
18. Baum D, Creer TL Medication compliance in children with asthma. J Asthma 1986, 23:49-59.
19. Beresford SA, Farmer EM, Feingold L, et al. Evaluation of a self-help dietary intervention in a primary care setting. Am J Public Health 1992, 82:79-84.
20. Ignacio-Garcia JM, Gonzalez-Santos P Asthma self-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med 1995, 151(2 Pt 1):353-359.
21. Grumbach K, Bodenheimer T Can health care teams improve primary care practice?. JAMA 2004, 291(10):1246-1251.
22. Sheldon DL Hope on hold. Am Med News 1997, 17-19.
23. Javors JR, Bramble JE Uncontrolled chronic disease: Patient noncompliance or clinical mismanagement?. Dis Manag 2003, 6(3):169-178.
24. Guidelines for the Diagnosis and Management of Asthma, Expert Panel Report 2, National Heart Lung and Blood Institute, NIH Publication No. 97-4051, July 1997.
25. Raba JM, Obis CB Health status of incarcerated urban males: Results of admission screening. J Prison Jail Health 1983, 3:6-24.
26. Executive Summary: Guidelines for the Diagnosis and Management of Asthma, National Asthma Education Program: Expert Panel Report: Publication No. 91-3042A. Bethesda, MD, National Asthma Education Program, Office of Prevention, Education and Control; National Heart, Lung and Blood Institute; National Institutes of Health, 1991.
27. National Commission on Correctional Health Care, Asthma Chronic Care Guidelines, at. http://www.ncchc.org/resources/clinicalguides.html.
28. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States: Level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med 2002, 166(8):1044-1049.
29. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994, 331:700-705.
30. Agertoft L, Pedersen S Effect of long-term treatment with inhaled corticosteroids on growth and pulmonary function in asthmatic children. Respir Med 1994, 88:373.
31. Hoge CW, Reichler MR, Dominguez EA, et al. An epidemic of pneumococcal disease in an overcrowded inadequately ventilated jail. N Engl J Med 1994, 331:643-648.
32. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997, 277:887-892.
33. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7). Hypertension 2003, 42:1206-1252.
34. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001, 103:1245-1249.
35. Jones DW, Appel LJ, Sheps SG, et al. Measuring blood pressure accurately. JAMA 2003, 289(8):1027-1030.
36. Perloff D, Grim C, Flack J, et al. Special report: Human blood pressure determination by sphygmomanometry Circulation 1993, 88(5):2460-2470.
37. Jones DW, Frohlich ED, Grim CM, et al. Mercury sphygmomanometers should not be abandoned: An advisory statement from the council for high blood pressure research, American Heart Association. Hypertension 2001, 37:185-186.
38. Canzanello VJ, Jensen PL, Schwartz GL Are aneroid sphygmomanometers accurate in hospital and clinic settings?. Arch Intern Med 2001, 161:729-731.
39. U.S. Preventive Services Task Force, High Blood Pressure Screening Recommendations, July 2003, at. http://www.ahrq.gov/clinic/uspstf/uspshype.htm.
40. Third Report of the National Cholesterol Education Program (NCEP), Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, September 2002, National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, NIH Publication No. 02-5215.
41. U.S. Preventive Services Task Force, Screening for Lipid Disorders in Adults, 2001, at. http://www.ahrq.gov/clinic/uspstf/uspschol.htm.
42. American Diabetes Association, National Diabetes Fact Sheet, 2002, at. http://www.diabetes.org/diabetes-statistics/national-diabetes-fact-sheet .jsp.
43. Centers for Disease Control and Prevention: The Burden of Chronic Diseases and Their Risk Factors. Most Common Causes of Death, United States, 1999.
44. Centers for Disease Control and Prevention, Chronic Disease Prevention, March 2004, at. http://www.cdc.gov/nccdphp/overview.htm.
45. American Diabetes Association Diabetes management in correctional institutions. Diabetes Care 2004, 27:S114-S121.
46. American Diabetes Association Screening for type 2 diabetes. Diabetes Care 2004, 27:S11-S14.
47. U.S. Preventive Services Task Force, Screening for Diabetes Mellitus, Adult Type 2, February 2003, at. http://www.ahrq.gov/clinic/uspstf/uspsdiab.htm.
48. National Commission on Correctional Health Care, Diabetes Chronic Care Guidelines, at. http://www.ncchc.org/resources/clinicalguides.html.
49. American Diabetes Association Preventive foot care in diabetes. Diabetes Care 2004, 27:S63-S64.
50. O'Hare JP, Hopper A, Madhave C, et al. Adding retinal photography to screening for diabetic retinopathy: A prospective study in primary care. Br Med J 1996, 312:679.
51. Grundy SM, Cleeman JI, Merz CN, et al. NCEP report: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004, 110:227-239.
52. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993, 329(14):977-986.
53. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352(9131):837-853.
54. National Heart Lung and Blood Institute, Obesity Education Initiative: The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD, October 2000, NIH Publication No. 00-4084.
55. American Diabetes Association Nutrition principles and recommendations in diabetes. Diabetes Care 2004, 27:S36.
56. U.S. Department of Agriculture, Dietary Guidelines for Americans, 2000, at. http://www.usda.gov/cnpp/.
57. Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
58. U.S. Preventive Services Task Force, Screening for Obesity in Adults, December 2003, at. http://www.ahrq.gov/clinic/uspstf/uspsobes.htm.
59. U.S. Department of Health and Human Services, Healthy People 2010, November 2000, at. http://www.healthypeople.gov/Publications/.
60. Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes: A systematic review. Am J Prev Med 2002, 22(4S):15-37.
61. Renders CM, Valk GD, Griffin SJ, et al. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: A systematic review. Diabetes Care 2001, 24(10):1821-1833.
62. Devinsky O Psychiatric comorbidity in patients with epilepsy: Implications for diagnosis and treatment. Epilepsy Behav 2003, 4(4):S2-S10.
63. Hauser WA, Hersdorffer DC Epilepsy, Frequency, Causes and Consequences 1990, Demos, New York.
64. Sander JW The epidemiology of epilepsy revisited. Curr Opin Neurol 2003, 16(2):165-170.
65. Gunn J, Fenton G Epilepsy in prisons: A diagnostic survey. Br Med J 1969, 4:326-328.
66. Novick LF, Penna RD, Schwartz MS, et al. Health status of the New York City prison population. Med Care 1977, 15(3):205-216.
67. Raba JM, Obis CB Health status of incarcerated urban males: Results of admission screening. J Prison Jail Health 1983, 3:6-24.
68. Delgado-Escueta AV, Mattson RH, King L, et al. Special report. The nature of aggression during epileptic seizures. N Engl J Med 1981, 305(12):711-716.
69. Whitman S, Coleman TE, Patmon C, et al. Epilepsy in prison: Elevated prevalence and no relationship to violence. Neurology 1984, 34:775-782.
70. Boylan LS, Flint LA, Labovitz DL, et al. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62:258-261.
71. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy Epilepsia 1981, 22:489-501. 30:389-399, 1989.
72. International League Against Epilepsy, Report of the International League Against Epilepsy Task Force on Classification and Terminology: A Proposed Diagnostic Schema for People with Epileptic Seizures and with Epilepsy, 2005, at. http://www.epilepsy.org/ctf/default.html.
73. Lowenstein D, Alldredge BK Status epilepticus. N Engl J Med 1998, 338(14):631-637.
74. Treatment of convulsive status epilepticus Recommendations of the Epilepsy Foundation of America's Working Group on status epilepticus. JAMA 1993, 270:854-859.
75. Devinsky O Patients with refractory seizures. N Engl J Med 1999, 340(20):1565-1570.
76. Nguyen D, Spencer S Recent advances in the treatment of epilepsy. Arch Neurol 2003, 60:929-935.
77. Efficacy and tolerability of the new antiepileptic drugs, I and, I. I. Neurology 2004, 62(8):1252-1273.